Drug-metabolizing enzymes: role in drug resistance in cancer G. KaurS. K. GuptaM. Verma Review Article 13 March 2020 Pages: 1667 - 1680
Chemo-radiotherapy integration in unresectable locally advanced non-small-cell lung cancer: a review E. BaldiniC. TibaldiC. Delli Paoli Review Article 04 March 2020 Pages: 1681 - 1686
Current updates on the role of reactive oxygen species in bladder cancer pathogenesis and therapeutics D. LiuX. QiuF. Pan Review Article Open access 18 March 2020 Pages: 1687 - 1697
Challenges in the treatment of breast cancer brain metastases: evidence, unresolved questions, and a practical algorithm I. MeattiniN. AndratschkeO. Kaidar Person Review Article 21 March 2020 Pages: 1698 - 1709
Exercise and cancer: a position statement from the Spanish Society of Medical Oncology M. PollánS. Casla-BarrioM. Martín Special Article Open access 13 February 2020 Pages: 1710 - 1729
THBS1 facilitates colorectal liver metastasis through enhancing epithelial–mesenchymal transition X. LiuD. XuB. Xing Research Article 12 February 2020 Pages: 1730 - 1740
Effects of different doses of propofol on the growth and expression of PCNA, CD34 and pAKT proteins in xenografted tumor of BALB/C mice with liver cancer Q. ZhouH. WuH. Wang Research Article 12 February 2020 Pages: 1741 - 1749
The efficacy and safety of immunotherapy targeting the PD-1 pathway for advanced urothelial carcinoma: a meta-analysis of published clinical trials F. ZhangZ. LiuX. Wang Research Article 21 February 2020 Pages: 1750 - 1761
RUNX1-activated upregulation of lncRNA RNCR3 promotes cell proliferation, invasion, and suppresses apoptosis in colorectal cancer via miR-1301-3p/AKT1 axis in vitro and in vivo G. XuH. WangK. Zhu Research Article 01 April 2020 Pages: 1762 - 1777
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice E. Pérez-RuizJ. Jiménez-CastroA. Rueda Research Article 24 February 2020 Pages: 1778 - 1785
Long noncoding RNA SNHG12 suppresses esophageal squamous cell carcinoma progression through competing endogenous RNA networks M. LiangZ. PanC. Chen Research Article 21 February 2020 Pages: 1786 - 1795
Malignancies after renal transplantation: experience of a Mexican referral center E. Leon-RodriguezA. Armengol-AlonsoP. Merchan-Alvear Research Article 19 February 2020 Pages: 1796 - 1801
VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30 Gy in five daily fractions E. La RoccaL. LozzaM. C. De Santis Research Article 04 March 2020 Pages: 1802 - 1808
Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival M. SallabandaM. I. García-BerrocalM. R. Magallón Research Article 02 March 2020 Pages: 1809 - 1817
Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors E. CocorocchioC. MartinoliP. Ferrucci Research Article 27 February 2020 Pages: 1818 - 1824
The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis K. HeydariA. ShamshirianR. Alizadeh-Navaei Research Article 27 February 2020 Pages: 1825 - 1837
PRDX2 plays an oncogenic role in esophageal squamous cell carcinoma via Wnt/β-catenin and AKT pathways A. L. FengX. HanZ. Yang Research Article 04 March 2020 Pages: 1838 - 1848
Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas D. ViñalD. MartinezA. Redondo Research Article 03 March 2020 Pages: 1849 - 1856
Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population E. CiruelosG. JerusalemP. Conte Research Article 13 March 2020 Pages: 1857 - 1866
Expression-based, consistent biomarkers for prognosis and diagnosis in lung cancer M. ArroyoR. LarrosaR. Bautista Research Article 16 March 2020 Pages: 1867 - 1874
Multifunctional nanocomposites MGO/FU-MI inhibit the proliferation of tumor cells and enhance the effect of chemoradiotherapy in vivo and in vitro X. PengC. YangH. Quan Research Article 13 March 2020 Pages: 1875 - 1884
Subtype-specific risk factors for postmenopausal breast cancer: findings from the PLCO trial O. Abdel-RahmanP. A. TangW. Y. Cheung Research Article 10 March 2020 Pages: 1885 - 1891
Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients Z. ZhaoH. MuY. Zhu Research Article 12 March 2020 Pages: 1892 - 1906
Letter to Editor regarding “The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta‑analysis” F. Rezaeeniya Correspondence 17 April 2020 Pages: 1907 - 1907
Reply to: “The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis” K. HeydariA. ShamshirianR. Alizadeh-Navaei Correspondence 15 May 2020 Pages: 1908 - 1908